mAbs · 2014 · 59 citations · 24 references
PharmacyBiochemistryBiotechnologyAntibody EngineeringMonoclonal AntibodiesProtein EngineeringAntibody CharacterizationAntibody FunctionAntibody StabilityMonoclonal Antibody TechnologySomatic HypermutationTherapeutic Antibody DevelopmentAntibodiesAntibody Affinity MaturationAntibody MaturationBiophysical CharacterizationMammalian Cell DisplaySomatic Hypermutation EngineeringThermal Stability EnhancementThermostability In Antibody Engineering
Antibody engineering to enhance thermostability may enable further application and ease of use of antibodies across a number of different areas. A modified human IgG framework has been developed through a combination of engineering approaches, which can be used to stabilize antibodies of diverse specificity. This is achieved through a combination of complementarity-determining region (CDR)-grafting onto the stable framework, mammalian cell display and in vitro somatic hypermutation (SHM). This approach allows both stabilization and maturation to affinities beyond those of the original antibody, as shown by the stabilization of an anti-HA33 antibody by approximately 10°C and affinity maturation of approximately 300-fold over the original antibody. Specificities of 10 antibodies of diverse origin were successfully transferred to the stable framework through CDR-grafting, with 8 of these successfully stabilized, including the therapeutic antibodies adalimumab, stabilized by 9.9°C, denosumab, stabilized by 7°C, cetuximab stabilized by 6.9°C and to a lesser extent trastuzumab stabilized by 0.8°C. This data suggests that this approach may be broadly useful for improving the biophysical characteristics of antibodies across a number of applications.
24
Design of therapeutic proteins with enhanced stability
Naresh Chennamsetty, Vladimir Voynov, Veysel Kayser et al. · Proceedings of the National Academy of Sciences · 2009 · 597 citations · Full text
Pharmacy, Biotechnology, Immunology +17
Beyond natural antibodies: the power of in vitro display technologies
Andrew Bradbury, Sachdev S. Sidhu, Stefan Dübel et al. · Nature Biotechnology · 2011 · 555 citations
Pharmacy, Biotechnology, Immunology +11
Biophysical Properties of Human Antibody Variable Domains
Stefan Ewert, Thomas Huber, Annemarie Honegger et al. · Journal of Molecular Biology · 2002 · 330 citations